scholarly article | Q13442814 |
P50 | author | John Q. Trojanowski | Q6253636 |
Nabila Dahodwala | Q67175779 | ||
Dag Aarsland | Q41599688 | ||
Inger van Steenoven | Q59846531 | ||
P2093 | author name string | Daniel Weintraub | |
David R Roalf | |||
John E Duda | |||
Paul J Moberg | |||
Howard Hurtig | |||
Lama M Chahine | |||
Alice Chen-Plotkin | |||
Jacqueline Rick | |||
P2860 | cites work | “Mini-mental state” | Q25938989 |
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 | ||
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease | Q33516505 | ||
Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging | Q33676115 | ||
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. | Q34024621 | ||
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. | Q34140404 | ||
Association between cognition and function in patients with Parkinson disease with and without dementia | Q34235570 | ||
Diagnostic criteria for Parkinson disease | Q34489839 | ||
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. | Q35234522 | ||
Development of quality of care indicators for Parkinson's disease | Q35673294 | ||
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease | Q36226625 | ||
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines | Q36810589 | ||
Clinical diagnostic criteria for dementia associated with Parkinson's disease | Q36836828 | ||
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force | Q37039871 | ||
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score | Q37369197 | ||
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment | Q37437501 | ||
Telephone interview for cognitive status: Creating a crosswalk with the Mini-Mental State Examination | Q37438471 | ||
Systematic review of levodopa dose equivalency reporting in Parkinson's disease. | Q37808677 | ||
Cognitive deficits in Parkinson's disease | Q41328582 | ||
The influence of education, social class and sex on Mini-Mental State scores. | Q43537725 | ||
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). | Q44028610 | ||
The economic impact of cognitive impairment in Parkinson's disease | Q44110131 | ||
The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years | Q44801054 | ||
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial | Q46853430 | ||
Defining mild cognitive impairment in Parkinson's disease | Q48212869 | ||
Montreal Cognitive Assessment: influence of sociodemographic and health variables | Q48745434 | ||
Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. | Q50646038 | ||
Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. | Q50971174 | ||
Characterizing mild cognitive impairment in Parkinson's disease. | Q51021258 | ||
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. | Q51875573 | ||
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. | Q51896723 | ||
Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. | Q51916987 | ||
Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). | Q51930615 | ||
Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. | Q51944818 | ||
Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. | Q51949961 | ||
Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. | Q51978817 | ||
Mental symptoms in Parkinson's disease are important contributors to caregiver distress. | Q51980927 | ||
Cognitive profile of patients with newly diagnosed Parkinson disease. | Q51987773 | ||
equate: Observed-Score Linking and Equating in R. | Q55262085 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dementia | Q83030 |
P304 | page(s) | 1809-1815 | |
P577 | publication date | 2014-11-07 | |
P1433 | published in | Movement Disorders | Q1486418 |
P1476 | title | Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease | |
P478 | volume | 29 |